BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30944042)

  • 1. Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.
    Bharambe HS; Paul R; Panwalkar P; Jalali R; Sridhar E; Gupta T; Moiyadi A; Shetty P; Kazi S; Deogharkar A; Masurkar S; Yogi K; Kunder R; Gadewal N; Goel A; Goel N; Chinnaswamy G; Ramaswamy V; Shirsat NV
    Acta Neuropathol Commun; 2019 Apr; 7(1):52. PubMed ID: 30944042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
    Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
    J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas.
    Kunder R; Jalali R; Sridhar E; Moiyadi A; Goel N; Goel A; Gupta T; Krishnatry R; Kannan S; Kurkure P; Deopujari C; Shetty P; Biyani N; Korshunov A; Pfister SM; Northcott PA; Shirsat NV
    Neuro Oncol; 2013 Dec; 15(12):1644-51. PubMed ID: 24203893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
    Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
    Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.
    Singh SV; Dakhole AN; Deogharkar A; Kazi S; Kshirsagar R; Goel A; Moiyadi A; Jalali R; Sridhar E; Gupta T; Shetty P; Gadewal N; Shirsat NV
    Biochem Biophys Res Commun; 2017 Sep; 491(4):946-952. PubMed ID: 28757413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth.
    Miele E; Po A; Mastronuzzi A; Carai A; Besharat ZM; Pediconi N; Abballe L; Catanzaro G; Sabato C; De Smaele E; Canettieri G; Di Marcotullio L; Vacca A; Mai A; Levrero M; Pfister SM; Kool M; Giangaspero F; Locatelli F; Ferretti E
    Mol Oncol; 2021 Feb; 15(2):523-542. PubMed ID: 32920979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy inhibition impairs the invasion potential of medulloblastoma cells.
    Paul R; Bharambe H; Shirsat NV
    Mol Biol Rep; 2020 Jul; 47(7):5673-5680. PubMed ID: 32621115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma.
    Bharambe HS; Joshi A; Yogi K; Kazi S; Shirsat NV
    Acta Neuropathol Commun; 2020 May; 8(1):70. PubMed ID: 32410663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells.
    Masurkar SA; Deogharkar A; Bharambe HS; Shirsat NV
    Biochem Biophys Res Commun; 2021 Sep; 568():76-82. PubMed ID: 34192607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.
    Jin Y; Xiong A; Zhang Z; Li S; Huang H; Yu TT; Cao X; Cheng SY
    Oncotarget; 2014 Jul; 5(13):4821-33. PubMed ID: 24970811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
    Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
    Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.
    Deogharkar A; Singh SV; Bharambe HS; Paul R; Moiyadi A; Goel A; Shetty P; Sridhar E; Gupta T; Jalali R; Goel N; Gadewal N; Muthukumar S; Shirsat NV
    Hum Mol Genet; 2021 Aug; 30(18):1721-1733. PubMed ID: 33949667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
    Sandén E; Dyberg C; Krona C; Visse E; Carén H; Northcott PA; Kool M; Ståhl N; Persson A; Englund E; Johnsen JI; Siesjö P; Darabi A
    J Neurooncol; 2015 May; 123(1):1-13. PubMed ID: 25820321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.
    Yogi K; Sridhar E; Goel N; Jalali R; Goel A; Moiyadi A; Thorat R; Panwalkar P; Khire A; Dasgupta A; Shetty P; Shirsat NV
    Oncoscience; 2015; 2(4):334-48. PubMed ID: 26097868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
    Li KK; Pang JC; Ching AK; Wong CK; Kong X; Wang Y; Zhou L; Chen Z; Ng HK
    Hum Pathol; 2009 Sep; 40(9):1234-43. PubMed ID: 19427019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastoma.
    Paul R; Bapat P; Deogharkar A; Kazi S; Singh SKV; Gupta T; Jalali R; Sridhar E; Moiyadi A; Shetty P; Shirsat NV
    Hum Mol Genet; 2021 Nov; 30(24):2416-2428. PubMed ID: 34274968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
    Murphy BL; Obad S; Bihannic L; Ayrault O; Zindy F; Kauppinen S; Roussel MF
    Cancer Res; 2013 Dec; 73(23):7068-78. PubMed ID: 24145352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.
    Li KK; Xia T; Ma FM; Zhang R; Mao Y; Wang Y; Zhou L; Lau KM; Ng HK
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):145-64. PubMed ID: 25041637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.